Eagle Bancorp Inc
EGBN Nasdaq State Commercial Banks Financials FY2016βFY2025
What Eagle Bancorp Inc does
No business description yet.
- Legal name
- EAGLE BANCORP INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 9, 2026
- Accession Β· CIK
- 0001050441-26-000021
0001050441
Revenue and margins
Eagle Bancorp Inc had $299M of revenue in fiscal 2025, down 3.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns and efficiency
For banks, return on equity and the efficiency ratio (costs as a share of revenue) say most about how well the business runs.
Dividends, buybacks and share count
Eagle Bancorp Inc returned $15.3M to shareholders in fiscal 2025, 74% of free cash flow. The diluted share count rose 0.6%.
Balance sheet
Loans, deposits and capital at each fiscal year end.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Deposits | $10.0B | $8.7B | $8.8B | $9.1B | $9.1B |
| Total assets | $11.8B | $11.2B | $11.7B | $11.1B | $10.5B |
| Shareholders' equity | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B |
| Goodwill | $104M | $104M | $104M | $0.0M | β |
| Intangible assets | $1.6M | $0.1M | $0.8M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $285M | $313M | $340M | $350M | $367M | $365M | $357M | $312M | $309M | $299M |
| Net interest income | $258M | $284M | $317M | $324M | $322M | $325M | $333M | $291M | $289M | $270M |
| Noninterest income | $27.3M | $29.4M | $22.6M | $25.7M | $45.7M | $40.4M | $23.7M | $21.5M | $19.9M | $29.3M |
| Noninterest expense | $115M | $119M | $127M | $140M | $144M | $149M | $165M | $153M | $275M | $201M |
| Provision for credit losses | $11.3M | $9.0M | $8.7M | $13.1M | $45.6M | β$20.8M | $0.3M | $31.5M | $66.4M | $293M |
| Interest expense | $27.6M | $40.1M | $76.3M | $106M | $68.4M | $40.0M | $91.7M | $335M | β | β |
| Pretax income | $159M | $186M | $204M | $197M | $176M | $238M | $190M | $128M | β$30.2M | β$196M |
| Income tax | $61.4M | $85.5M | $51.9M | $53.8M | $43.9M | $61.0M | $48.8M | $27.0M | $16.8M | β$58.1M |
| Net income | $97.7M | $100M | $152M | $143M | $132M | $177M | $141M | $101M | β$47.0M | β$138M |
| Net income to common | $97.7M | $100M | $152M | $143M | $132M | $177M | $141M | $101M | β$47.0M | β$138M |
| Diluted EPS | $2.86 | $2.92 | $4.42 | $4.18 | $4.09 | $5.52 | $4.39 | $3.31 | β$1.56 | β$4.55 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $117M | $161M | $165M | $133M | $133M | $238M | $195M | $196M | $124M | $28.5M |
| Capital expenditure | $7.4M | $5.8M | $1.5M | $2.8M | $2.9M | $5.3M | $2.1M | $0.1M | $0.3M | $7.7M |
| Free cash flow | $109M | $155M | $164M | $130M | $130M | $233M | $193M | $196M | $123M | $20.8M |
| Depreciation and amortization | $6.2M | $6.9M | $7.0M | $6.2M | $4.7M | $5.9M | $3.3M | $3.5M | $3.2M | $2.9M |
| Stock-based compensation | $6.9M | $5.6M | $6.5M | $7.7M | $5.3M | $7.8M | $9.9M | $10.0M | $9.6M | $7.0M |
| Share buybacks | β | β | $0.0M | $54.9M | $61.4M | $0.7M | $33.1M | $48.0M | $0.0M | $0.0M |
| Dividends paid | β | β | $0.0M | $22.3M | $28.3M | $44.7M | $55.8M | $55.0M | $45.6M | $15.3M |
| Dividends and buybacks | β | β | $0.0M | $77.2M | $89.8M | $45.4M | $88.9M | $103M | $45.6M | $15.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $368M | $190M | $322M | $242M | $1.8B | $1.7B | $312M | $723M | $633M | $696M |
| Total debt | $618M | $618M | $248M | $499M | $595M | $394M | $1.1B | $1.4B | $566M | $76.4M |
| Loans, net | $5.6B | $6.3B | $6.9B | $7.5B | β | β | β | β | β | β |
| Deposits | $5.7B | $5.9B | $7.0B | $7.2B | $9.2B | $10.0B | $8.7B | $8.8B | $9.1B | $9.1B |
| Property and equipment, net | $20.7M | $21.0M | $16.9M | $14.6M | $13.6M | $14.6M | $13.5M | $10.2M | $7.7M | $12.8M |
| Goodwill | $104M | $104M | $104M | $104M | $104M | $104M | $104M | $104M | $0.0M | β |
| Intangible assets | β | β | β | β | $0.9M | $1.6M | $0.1M | $0.8M | β | β |
| Total assets | $6.9B | $7.5B | $8.4B | $9.0B | $11.1B | $11.8B | $11.2B | $11.7B | $11.1B | $10.5B |
| Total liabilities | $6.0B | $6.5B | $7.3B | $7.8B | $9.9B | $10.5B | $9.9B | $10.4B | $9.9B | $9.4B |
| Shareholders' equity | $843M | $950M | $1.1B | $1.2B | $1.2B | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B |
| Margins | ||||||||||
| Net margin | 34.2% | 32.0% | 44.8% | 40.9% | 36.0% | 48.4% | 39.5% | 32.2% | β15.2% | β46.1% |
| FCF margin | 38.3% | 49.5% | 48.3% | 37.1% | 35.5% | 63.9% | 54.1% | 62.7% | 40.0% | 6.9% |
| Net interest share of revenue | 90.4% | 90.6% | 93.3% | 92.7% | 87.6% | 88.9% | 93.4% | 93.1% | 93.5% | 90.2% |
| Efficiency ratio | 40.3% | 37.8% | 37.3% | 40.0% | 39.3% | 40.9% | 46.3% | 49.1% | 89.0% | 67.1% |
| Returns | ||||||||||
| Return on equity | 11.6% | 11.2% | 14.8% | 12.4% | 10.9% | 13.6% | 10.9% | 8.0% | β3.8% | β11.7% |
| Return on assets | 1.4% | 1.4% | 1.9% | 1.6% | 1.3% | 1.5% | 1.2% | 0.9% | β0.4% | β1.3% |
| Return on tangible equity | 13.2% | 11.8% | 15.2% | 13.2% | 11.6% | 14.2% | 12.5% | 8.6% | β3.8% | β12.2% |
| Growth | ||||||||||
| Revenue growth | β | 9.7% | 8.4% | 3.0% | 5.0% | β0.6% | β2.3% | β12.5% | β1.1% | β3.1% |
| Net income growth | β | 2.6% | 51.9% | β6.1% | β7.5% | 33.6% | β20.2% | β28.7% | β146.8% | β |
| EPS growth | β | 2.1% | 51.4% | β5.4% | β2.2% | 35.0% | β20.5% | β24.6% | β147.1% | β |
| FCF growth | β | 41.8% | 5.7% | β20.8% | 0.3% | 79.1% | β17.3% | 1.4% | β36.9% | β83.2% |
| Share count change | β | 0.4% | 0.4% | β0.7% | β5.4% | β1.1% | 0.2% | β5.3% | β0.8% | 0.6% |
| Financial health | ||||||||||
| Debt / equity | 0.7x | 0.7x | 0.2x | 0.4x | 0.5x | 0.3x | 0.9x | 1.1x | 0.5x | 0.1x |
| Loans / deposits | 98.3% | 108.4% | 99.2% | 103.4% | β | β | β | β | β | β |
| Provision / loans | 0.2% | 0.1% | 0.1% | 0.2% | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 2.6% | 1.8% | 0.4% | 0.8% | 0.8% | 1.4% | 0.6% | 0.0% | 0.1% | 2.6% |
| Stock comp / revenue | 2.4% | 1.8% | 1.9% | 2.2% | 1.4% | 2.1% | 2.8% | 3.2% | 3.1% | 2.4% |
| Payouts / FCF | β | β | 0.0% | 59.5% | 68.9% | 19.5% | 46.1% | 52.7% | 37.0% | 73.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 5.0 | 3.0 | 5.0 | 6.0 | 4.0 | 4.0 | 5.0 | 4.0 |
| Accruals ratio | β0.3% | β0.8% | β0.2% | 0.1% | β0.0% | β0.5% | β0.5% | β0.8% | β1.5% | β1.5% |
Source: SEC EDGAR XBRL filings (CIK 0001050441). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.